Systematic investigation and in vitro biocompatibility studies on mesoporous europium doped hydroxyapatite by Popa, Cristina, et al.
Systematic investigation and in vitro biocompatibility
studies on mesoporous europium doped hydroxyapatite
Cristina Popa, Carmen Steluta Ciobanu, Simona Liliana Iconaru, Miruna
Stan, Anca Dinischiotu, Constantin C. Negrila, Mikael Motelica-Heino, Re´gis
Gue´gan, Daniela Predoi
To cite this version:
Cristina Popa, Carmen Steluta Ciobanu, Simona Liliana Iconaru, Miruna Stan, Anca Dinis-
chiotu, et al.. Systematic investigation and in vitro biocompatibility studies on mesoporous
europium doped hydroxyapatite. Central European Journal of Chemistry, Springer Verlag,
2014, 12 (10), pp.1032-1046. <10.2478/s11532-014-0554-y>. <insu-01017548>
HAL Id: insu-01017548
https://hal-insu.archives-ouvertes.fr/insu-01017548
Submitted on 2 Jul 2014
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

Systematic investigation and in vitro biocompatibility studies on mesoporous europium 
doped hydroxyapatite 
Cristina Liana Popa 
National Institute of Materials Physics, Atomistilor Str., No. 105 bis PO Box MG 7, 077125, 
Magurele, Romania.  
 
Carmen Steluta Ciobanu,  
National Institute of Materials Physics, Atomistilor Str., No. 105 bis PO Box MG 7, 077125, 
Magurele, Romania.  
 
Simona Liliana Iconaru  
National Institute of Materials Physics, Atomistilor Str., No. 105 bis PO Box MG 7, 077125, 
Magurele, Romania.  
Institute for Eath Sciences, UMR 7327, CNRS-University of Orléans, 1A Rue de la Férrolerie, 
45071 Orléans cedex 02, France 
 
Miruna Stan,  
Department of Biochemistry and Molecular Biology, University of Bucharest, 91-95 Spl. 
Independentei, 050095, Bucharest, Sector 5, Romania 
 
Anca Dinischiotu,  
Department of Biochemistry and Molecular Biology, University of Bucharest, 91-95 Spl. 
Independentei, 050095, Bucharest, Sector 5, Romania 
 
Constantin Catalin Negrila, 
National Institute of Materials Physics, Atomistilor Str., No. 105 bis PO Box MG 7, 077125, 
Magurele, Romania.  
 
Mikael Motelica-Heino,  
Institute for Earth Sciences, UMR 7327, CNRS-University of Orléans, 1A Rue de la Férrolerie, 
45071 Orléans cedex 02, France 
 
Regis Guegan, 
Institute for Earth Sciences, UMR 7327, CNRS-University of Orléans, 1A Rue de la Férrolerie, 
45071 Orléans cedex 02, France 
 
Daniela Predoi  
National Institute of Materials Physics, Atomistilor Str., No. 105 bis PO Box MG 7, 077125, 
Magurele, Romania. *dpredoi@gmail.com 
 
 
 
 
 
 
Abstract 
This paper reports a systematic investigation on europium doped hydroxyapatite (Eu:HAp). In 
this work, a set of complementary techniques Fourier Transform Infrared spectroscopy (FTIR), 
X-ray photoelectron spectroscopy (XPS), transmission electron microscopy (TEM) and, 
Brunauer–Emmett–Teller (BET) technique was used to allowing a proper understanding of 
Eu:HAp. The XPS analysis confirmed the substitution of Ca ions by Eu ions in Eu:HAp samples. 
Eu:HAp and pure HAp show the isotherms of type IV with a hysteresis loop at a relative 
pressure (P/P0) between 0.4 and 1.0, indicating the presence of mesopores. Finally, the in vitro 
biological effects of Eu:HAp nanoparticles were evaluated by focusing on F-actin filaments 
pattern and heat shock proteins (Hsp) expression in HEK293 human kidney cells. Fluorescence 
microscopy studies of the actin protein revealed no changes of the immunolabeling profile in the 
renal cells cultured in the presence of Eu:HAp nanoparticles. Hsp60, Hsp70 and Hsp90 
expression measured by Western blot analysis were not affected after a 24 and 48 hours 
exposure. These results confirmed the lack of nanoparticles’ toxicity and the biocompatibility of 
Eu:HAp nanoparticles and their possibility possible uses of using them in medical purposes 
without affecting the renal function. 
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1. Introduction 
Hydroxyapatite (HAp) is one of the most studied inorganic materials due to its excellent 
biological properties. Belonging to the apatite family, HAp, with the general formula, 
Ca10(PO4)6(OH)2 constitutes the most important  inorganic component of bones and teeth of 
about 65% of the total mineral content of the human bone mineral component, being the most 
important  inorganic component of bones and teeth [1-5]. Moreover, synthetic HAp has given 
promising results in the area of drug storage and damaged bone reconstruction. Intensive studies 
have shown an incredible biocompatibility, osteoconductivity, non-toxic and non-inflammatory 
properties. HAp nanostructures are suitable for both bio-imaging and drug delivery. Among the 
several routes for the synthesis of HAp, the co-precipitation method has attracted great attention 
with its ability to generate nanoscale particles and nanocrystalline powders at low processing 
temperature. By co-precipitation method both size and morphology of the synthesized 
nanoparticles can be controlled which is of fundamental importance in the process of calcium 
phosphate deposition to the formation of renal stones [6]. 
One of the most important properties of hydroxyapatite is the ability to incorporate a wide 
variety of substitutions for Ca2+, PO43- and/or OH- ions based on the flexibility of the apatite 
structure. Trivalent europium Eu ions have been used as luminescent probes in the investigation 
of crystallographic structure of activator centres, as well as a tool to probe the local symmetry 
and occupancy of cationic sites in apatite structures. A. Doat et al. showed that Eu3+ ion 
luminescence can be obtained under visible irradiation [7]. Eu3+ ion luminescence obtained by 
visible irradiation is suitable for prolonged examination of living cells. Different synthesis 
techniques for the study of the substitution of Ca2+ by Eu3+ ions have been reported in previous 
research. R.S. André et al. [8] obtained, by using a microwave hydrothermal method, Eu-doped 
hydroxyapatite (Eu:HAp) nanorod with diameters from 9 to 26 nm. Eu3+ ions were used as a 
marker in the HAp network by basic hydrolysis followed by the microwave hydrothermal 
method synthesis treatment process. C.A. Barta et al. reported that Eu3+ ions have the potential 
for the treatment of bone density disorders such as osteoporosis [9]. However, the as-prepared 
Eu3+/Gd3- doped HAp nanorods by F. Chen et al. [10] exhibited inappreciable in vitro cell 
toxicity and showed a high drug adsorption capacity and sustained ibuprofen release as a model 
drug, governed by a diffusion process. The cytotoxicity, drug adsorption and release, as well as 
in vitro/in vivo MR/luminescence/computed tomography (CT) imaging of Eu3+ and Gd dual 
doped HAp nanorods were also investigated by F. Chen et al. [10]. Recently, E. Boanini et al. 
[11] provided an overview of the recent results achieved on ion-substituted calcium phosphates 
prepared at low temperature by direct synthesis in aqueous medium or by hydrolysis of more 
soluble calcium phosphates. In recent years, C.S. Ciobanu et al. [12] reported a novel co-
precipitation adapted synthesis for europium doped hydroxyapatite (Eu:HAp). They have 
synthesized europium-doped hydroxyapatite nanoparticles by co-precipitation method at low 
temperature and have shown by XRD studies that Eu3+ have been successfully inserted into 
HAp. Their results revealed that the obtained Eu:HAp (xEu≥ 0) particles are well assigned to the 
hexagonal lattice structure of the hydroxyapatite phase. On the other hand, their resultants 
showed the prepared Eu:HAp samples conserved regular ellipsoidal morphology and the doping 
with Eu3+ had little influence on their morphology. 
The aims of this work concerns the study of the effects of Eu doping on a wide concentration 
range on the phisico-chemical properties of the Eu:Hap samples. The samples were characterized 
by various techniques including: transmission electron microscopy (TEM), BET and X-ray 
photoelectron spectroscopy (XPS). Up to now, the report on the comprehensive study in which a 
surface sensitive technique, XPS, has been not found. 
On the other hand, we report for the first time the effects of europium-doped hydroxyapatite 
nanoparticles in terms of morphology and size in human kidney cells (HEK293) response 
regarding the actin cytoskeletal filaments disposition and heat shock proteins expression. 
Although it is well known that hydroxyapatite represents a mineral involved in osteogenesis, it is 
also responsible for nephrolithiasis [13] because an important percent of renal stones contain 
calcium phosphate in the form of hydroxyapatite [14]. Taking into account that the shape and 
dimension of hydroxyapatite nanoparticles are important parameters in the process of phosphate 
renal stones formation [15], this study aims to evaluate the renal cells response to the nanoscale 
particles synthesized by co-precipitation method. 
2. Materials and methods 
2.1  Synthesis of the samples.  
Europium doped hydroxyapatite, Ca10-xEux(PO4)6(OH)2 with xEu=0 (pure HAp), xEu=0.01, 
xEu=0.02, xEu=0.2 were synthesized by a co-precipitation method at 1000C mixing 
Eu(NO3)36H2O, Ca(NO3)24H2O and (NH4)2HPO4 in deionized water in agreement with [12,16]. 
2.2  Characterization techniques.  
Transmission electron microscopy (TEM) analyses were carried out using a JEOL 200 CX. 
The specimen for TEM imaging was prepared from particle suspensions in deionised water. A 
drop of well-dispersed supernatant was placed on a carbon – coated 200 mesh copper grid, 
followed by drying the sample at ambient conditions before it is attached to the sample holder on 
the microscope. 
 The functional groups present in the prepared nanoparticles and thin films were identified 
by FTIR using a Perkin Elmer Spectrum BX spectrometer. In order to obtain the nanoparticles 
spectra, 1% of the nano-powder was mixed and ground with 99% KBr. Tablets of 10 mm 
diameter were prepared by pressing the powder mixture with a pressure of not more than 
0.69.105 Pa. The spectrum was recorded in the range of 400 to 4000 cm-1 with 4 cm-1 resolution. 
The first FTIR spectra were obtained after 256 scans at room temperature (25 ± 0.5°C). The data 
interpretation was done according to [17-19].  
X-ray photoelectron spectroscopy (XPS) measurements were carried out on a SPECS 
Multimethod Surface Analysis System using monocromatic Al Kα radiation (1486.6 eV). The 
vacuum in the analyzer chamber was p ~ 3 × 10-9 torr. The X-rays are emitted by an anti-cathode 
of Al, U = 12.5 kV, filament emission current I = 20 mA. For charge compensation a FG40 flood 
gun had been used, providing an electron beam of 2 eV and 0.3 mA. The XPS recorded spectrum 
involved an energy window w = 20 eV with the resolution R = 20 eV, and with 400 recording 
channels. The XPS spectra recorded were processed using Spectral Data Processor v2.3 (SDP) 
software. N2 adsorption/desorption analysis was performed at 77 K using a Micrometrics model 
ASAP 2020 analyser. The specific surface area was determined by the Brunauer–Emmett–Teller 
(BET) method [20]. The pore parameters (pore volume and pore diameter) were evaluated from 
the desorption branch of the isotherm based on the Barrett–Joyner–Halenda (BJH) model [21]. 
The mean pore diameter, Dp, was calculated from Dp = 4VT/S [20], where VT is the total 
volume of pores, and S is the BET surface area. 
2.3 Biological studies 
2.3.1 Cell culture.  
HEK 293 cell line (ATCC CRL-1573), derived from human embryonic kidney cells, was 
maintained in DMEM medium containing 10% fetal bovine serum, 100 U/ml penicillin and 100 
µg/ml streptomycin, in a humidified atmosphere (5% CO2) at 370C. The culture medium was 
changed every 2 days until cells reached confluence and then were trypsinized with 0.25% (w/v) 
Trypsin - 0.53 mM EDTA (Sigma-Aldrich). 
2.3.2 F-actin staining.  
HEK 293 cells were seeded onto six-well plates (3 x 104 cells/ well) and exposed to 100 
µg/mL of 0%, 1%, 2% and 20% Europium doped hydroxyapatite. After 24 and 48 hours of 
treatment, the medium was removed, and the cells were fixed in 4% paraformaldehyde for 20 
minutes at 4°C and permeabilized with 0.5% Triton X-100 for 1 hour. After three washes with 
PBS, the cells were incubated for 30 min in PBS containing 20 µg/mL phalloidin – FITC 
(Sigma-Aldrich). The nuclei were counterstained with 2 µg/mL DAPI (Invitrogen). The cells 
were observed using an Olympus IX71 fluorescent microscope with the excitation wavelengths 
set to 495 nm and 358 nm, and the emission wavelengths set to 513 nm and 461 nm for FITC 
and DAPI signal detection, respectively.     
2.3.3 Western Blot analysis.  
For determination of chaperones (Hsp60, Hsp70 and Hsp90) expression at protein level, 
Western blot analysis was performed. The cells were cultured in the presence of appropriate 
medium and after 24 or 48 hours of treatment (25 or 100 µg/mL of 0%, 1%, 2% and 20% 
Europium doped hydroxyapatite) were harvested in lysis buffer (150 mM NaCl, 1% Triton X-
100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 8.0 and protease inhibitor 
cocktail) and incubated for 30 min on ice. Cell lysates were clarified by centrifugation at 13,000 
g for 20 min and supernatants collected were boiled (950C) for 5 min. Equal amounts of total 
protein were subjected to SDS-polyacrylamide gel electrophoresis. Proteins were transferred to 
Hybond-PVDF membranes in Tris-glycine buffer (48 mM Tris-HCl, pH 8.3, 39 mM glycine, 
20% methanol) using a wet transfer unit (BIO-RAD, USA), and after that, membranes were 
blocked overnight at 4°C, and incubated with specific mouse monoclonal IgG anti-HSPs (all 
from Santa Cruz Biotechnology) and anti-β-actin (from Sigma-Aldrich). The Western Blot 
Chromogenic Immunodetection Kit (INVITROGEN) which contains secondary antibody anti-
mouse IgG conjugated with alkaline phosphatase and BCIP/NBT substrate for alkaline 
phosphatase were used according to manufacturer’s instructions. Densitometry data were 
analyzed by GelQuantNET software for semi-quantification of HSPs and beta-actin. 
Whole cell lysates of control (Ctrl) and europium-doped hydroxyapatite treated cells were 
separated on 10% SDS-PAGE, transferred to PVDF membrane that was incubated with anti-
Hsp60, anti-Hsp70 and anti-Hsp90 antibodies. 
β-actin expression was used as a loading control. One representative blot was figured for 24 
and 48 hours of treatment (A). The densities of HSPs bands were measured and the content was 
normalized against β-actin. Results indicate the percentage of control group. Values are shown as 
mean ± S.D. from three independent experiments, each performed in triplicate. 
Statistical analysis. All experiments were done in triplicate and measurements repeated at least 
three times. The results w ere expressed as percent of the control values. Data are represented as 
mean ± standard deviation. 
3. Results  
3.1  Structure, formation and morphology of pure HAp and Eu:Hap 
The crystal structure of the prepared samples was verified by X-ray diffraction (XRD) [12]. 
The XRD patterns of the Eu:HAp, Ca10-xEux(PO4)6(OH)2, with different xEu values (xEu=0.01, 
0.02 and 0.2) and HAp (xEu=0) confirmed the hexagonal lattice symmetry (space group P63/m) 
for all samples.  In previous studies [12-22] it was shown that all the XRD patterns of Eu:HAp 
samples and pure HAp can be well indexed as a hexagonal phase agreeing well with the values 
of the standard ASTM data (JCPDS no. 9-0432) indicating a moncrystalline hydroxyapatite 
phase. Fig. 1 displays the HRTEM images and Selected Areas Electron Diffraction (SAED) of 
Eu:HAp nanoparticles with xEu = 0.02 and confirms that the synthesized samples are well-
crystallized even at small values of xEu. In the HRTEM image (Fig. 1 B) it can be seen that the 
crystalline phase of hydroxyapatite with well-resolved lattice fringes can be observed. The 
distances (2.81Å and 1.84Å) between the adjacent lattice fringes is in accordance with the 
d211and d213 spacing values reported in literature (0.2814 nm and 0.184 nm) (JCPDS no. 09-
0432). The HRTEM images of the sample further confirm that the synthesized samples are well 
crystallized single crystals. 
 
 Figure 1. HRTEM image of Eu:HAp with xEu= 0.02. 
 
In the 4000 cm-1 to 400 cm-1 range, in Fig. 2, are shown the IR absorbance spectra of 
Eu:HAp samples with various europium concentrations (0≤xEu≤ 0.2).  
 
 
Figure. 2. FTIR spectra of europium doped hydroxyapatite (Eu:HAp) with xEu=0 (black), 
xEu=0.01 (red), xEu=0.02 (green), xEu=0.05 (dark blue), xEu=0.1 (light blue) and xEu=0.2 (purple). 
 In our previous studies [23] we have shown that for all the samples the presence of strong OH- 
vibration peak (632 cm−1) could be noticed. The presence of the broad bands of adsorbed water 
in the regions 1600–1700 cm−1 and 3200–3600 cm−1 are due to characteristic OH- modes (Figure 
2). Furthermore, in the last studies on apatites [24] has been reported that the band at 3570 cm−1 
(stretching) is characterized by OH- vibrational mode and the band at 632 cm−1 characterized by 
OH- arises from stretching librational mode.  
In agreement with A. Slosarczyk et al. [25] the most noticeable feature in these spectra 
concerns the  presence of the typical 4 PO43-   and 3 PO43- IR vibrations of phosphates group 
belonging to apatite in the range from 530–650 cm−1 and 900–1200 cm−1 respectively [26]. The 
bands at around 1090 cm−1 and about1040 cm−1 can be attributed to the 3 PO4 while the band at 
962 arises from 1 PO4. The 602 cm−1 and 564 cm−1 bands appear from 4 PO4. Markovik et al. 
[27], presented that the sharpness of bands, especially sharpness of the 632 cm−1, 602 cm−1 and 
564 cm−1 bands indicate a well-crystallized HAp. The band at 475 cm−1 can be attributed to the 2 PO4.  
On the other hand, in the second derivative spectra the band at 475 cm-1 was identified a 2(PO43-). In concordance with precedent studies [23, 28], the bands assigned in the second 
derivative spectra of Eu:HAp (0≤xEu≤0.2) can be attributed to molecular vibrations of the 
phosphate (PO43-) in a apatitic stoichiometric environment of hydroxyapatite [28]. 
In the FT-IR spectrum of Eu:HAp with xEu  0.1 (Fig. 2) the bands corresponding to the 3 
vibration of C–O were observed at 1410 cm−1, characteristic of the carbonate group [29-30]. 
The intensity of the band located at 1410 cm−1 in the spectrum of Eu:HAp samples with xEu  
0.1 is attributed to components of the 3  mode of a trace amount of CO32-. The 2 vibrations 
between 850 and 890 cm−1, characteristic of the carbonate group were not detected because 2 
CO3 band at 872 cm−1 is hidden by HPO4 band at 875 cm-1. Similar comportment was observed 
by M. Markovik et al. [27] in his studies on preparation and comprehensive characterization of 
calcium hydroxyapatite. M. Markovik et al. and D.W. Holcomb et al. [31] showed that the CO3 
band at 1410 cm−1 derives from CO32- (designated by “B-type” carbonate that replace PO43- ions 
in the hydroxyapatite lattice). The band at 1510 cm−1 was also detected in the FT-IR spectrum of 
Eu:HAp with xEu0.1. The band at 1510 cm−1 derives from CO32- (designated by “A-type” 
carbonate) that replaces OH- ions in the hydroxyapatite lattice [27, 32]. In all the spectra of 
Eu:HAp samples, the band at 875 cm-1 was detected. This band is supposed to arise due to 
HPO42- ions from several reasons [27].  
In order to investigate the successful doping of Eu in Eu:Hap, X-ray photoelectron 
spectroscopy (XPS) measurements were performed. High resolution spectra of the C 1s, Ca 2p, P 
2p, O 1s and Eu 3d regions were obtined.  
 Figure 3. High-resolution XPS spectra and curve-fitting results of carbon C 1s for Eu:HAp 
(xEu=0.01, xEu=0.02, xEu=0.2) and pure HAp (xEu=0) samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. High-resolution XPS spectra and curve-fitting results of oxygen O 1s for Eu:HAp 
(xEu=0.01, xEu=0.02, xEu=0.2) and pure HAp (xEu=0) samples. 
 
 Figure 5. High-resolution XPS spectra and curve-fitting results of calcium Ca 2p for 
Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) and pure HAp (xEu=0) samples. 
 
Figure 6. High-resolution XPS spectra and curve-fitting results of phosphorous P 2p for Eu:HAp 
(xEu=0.01, xEu=0.02, xEu=0.2) and pure HAp (xEu=0) samples. 
 
 
The measured binding energy (EB) scale was referenced to a C 1s  at the EB value of 284.8 
eV [33]. Figure 3 shows the high–resolution C 1s spectra for the Eu:HAp (xEu=0.01, xEu=0.02, 
xEu=0.2) and pure HAp (xEu=0) samples. Decomposition of multiple peaks in the C 1s region was 
performed and each spectrum had a shoulder on the higher-binding-energy side in addition to the 
main peak around 284.8 eV. For the samples with xEu=0.02 and xEu=0.2 a new peak is observed 
at around 283.4 eV. The peaks at 284.8 eV and 283.4 eV correspond to residual or adventitious 
carbon. In the opinion of J. Serra et al. [34] the peak positioned at 284.8 eV, corresponds to C–C 
and C–H bonds.  
The peak positioned at 283.4 eV could correspond to C-metal bonds, showing a chemical 
interaction between Eu and contaminants from surface layer. The O 1s, Ca 2p, P 2p 
photoelectron peaks were decomposed according to the binding energies of carbon bonds in 
hydroxyapatite [35-36].  
Figure 4 shows the high resolution XPS spectra of oxygen O 1s for Eu:HAp, Ca10-
xEux(PO4)6(OH)2, with different xEu values and pure HAp. The peak from 531.4 eV corresponds 
to hydroxyl groupings resulting from the chemisorption of water or oxygen. These results are in 
accordance with previous studies of J.F. Moulder et al. [37]. The peak position of the hydroxyl 
ion (OH-) was reported as EB=531.8 eV on a SnOx surface [38]. On the other hand, T. Kawabe et 
al. [39] consider that two oxygen species, i.e., O- and OH-, may be included in the resolved peak 
at 531.2 eV. Furthermore, the peak position of chemisorbed oxygen species O- on nickel was 
reported as binding energy, EB=531.0-531.5 eV [40-42]. Figure 5 presents the high-resolution Ca 
2p spectra for Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) and pure HAp (xEu=0) samples. The Ca 2p 
band of the as-prepared samples exhibits a well-resolved doublet with a Ca 2p3/2 component and 
a Ca 2p1/2 component. Increasing the europium concentration, the binding energies shift slightly 
from 347.2 eV for the pure HAp (xEu=0) to 347.7 eV for the Eu:HAp (xEu=0.2). The peak located 
at about 347.2 eV shows that the calcium atoms are bonded with a phosphate group (PO43-). 
Moreover, S. Kaciulis et al. have shown [43] that the shift towards higher binding energy for the 
Eu:HAp samples indicates that the amount of crystalline HAp has increased.    
After the deconvolution data processing, the P 2p photoelectron line consists of one single 
peak, at around EB=133.1eV for pure HAp (xEu=0) and Eu:HAp (xEu=0.01, xEu=0.02 and 
xEu=0.2) samples [44]. The high-resolution XPS spectra and curve-fitting results of phosphorous 
P 2p for Eu:HAp and pure HAp samples are exhibited in Figure 6. T.F. Stoica et al. showed [45] 
that the P 2p photoelectron line consists of one single peak at EB position of 133.4 eV. Moreover, 
in agreement with previous XPS studies reported [46], the binding energy of the photoelectron 
peaks for Ca and P are characteristic to their full oxidation states (Ca2+ and P5+) for 
hydroxyapatite.  
The high-resolution XPS spectra of the Eu 3d region (Figure 7) shows the presence of 
europium in the form of Eu3+ in Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) samples. For Eu 3d3/2 the 
peak appears at a binding energy of 1136.5 eV. These results indicate that europium ions were 
successfully incorporated into the HAp lattice. The Ca/P ratios were 1.67 of the nanocrystalline 
pure HAp (xEu=0) and 1.64 of europium doped hydroxyapatite (Eu:HAp). In agreement with J. 
Nathanael et al., [47] the decrease of Ca/P ratio in the Eu:HAp can obviously be linked to the 
substitution of Ca ions by Eu ions. 
 
 Figure 7. High-resolution XPS spectra and curve-fitting results of phosphorous Eu 3d for 
Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) samples. 
 
 
Porosity of Eu:HAp and pure HAp samples were measured using the nitrogen physisorption 
technique. Figure 8 shows the representative adsorption–desorption isotherms of the Eu:Hap 
with different xEu values (xEu=0.01, 0.02 and 0.2) and HAp (xEu=0). All the samples show 
isotherms of type IV [48], with a hysteresis loop at a relative pressure (P/P0) between 0.4 and 
1.0, indicating the presence of mesopores. For all the samples the shape of the hysteresis loop is 
of type H1 which demonstrates the properties of typical mesoporous materials [49].  
 
Figure 8. N2 adsorption–desorption isotherms of Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) and pure 
HAp (xEu=0) samples. 
 
Figure 9. Pore size distribution of Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) and  pure HAp (xEu=0) 
samples. 
  
In accord with [50-51], these mesopores are usually formed due to the agglomeration of 
primary crystallites. As shown in Figure 8, the order of BET specific surface areas and Langmuir 
specific surface areas are as follows: Eu:HAp (xEu=0.2) > Eu:HAp (xEu=0.02) > Eu:HAp 
(xEu=0.01)>HAp (xEu=0). The pore size distributions measured using the BJH method is 
presented in Figure 9. The maximum BET surface area, Langmuir surface area, and the 
maximum pore volume obtained were 130.21 m2/g, 192,091m2/g and 0.49 cm3/g, respectively 
for the samples of Eu:HAp with xEu=0.2. The average pore diameter value, Dp, increases from 
5.61 to 7.83 nm when xEu increases. The properties of the tested samples are summarized in 
Table 1. 
 
Table 1. BET surface area, Langmuir surface area, pore size and pore volume of Eu:HAp 
samples and pure HAp. 
Samples xEu BET surface area 
(m2/g) 
Langmuir surface 
area (m2/g) 
Pore size 
(nm) 
Pore volume 
(cm3/g) 
Dp  
(nm) 
Eu:HAp 0.01 112.90 167.72 22.04 0.43 5.07 
0.02 115.96 171.26 16.56 0.48 5.61 
0.20 130.21 192.091 14 0.49 6.74 
HAp 0 71.88 107.27 24.36 0.41 7.83 
 
3.2 Biological studies 
Our previous biocompatibility studies of Eu doped crystalline hydroxyapatite bioceramics 
[22]  showed no significant decrease of viability of the HEK293 cell line and low levels of 
intracellular lipid peroxidation in the Eu-doped HAp treated cells. In order to visualize how Eu-
doped hydroxyapatite influences the adhesion and proliferation of HEK293 cells, a phalloidin-
FITC staining for F-actin was performed.  F-actin is a highly conserved and abundant 
cytoskeletal protein in eukaryotic cells. It is implicated in maintaining the cellular architecture 
and mediating cell movements [52]. As shown in Figure 10 and 11, the cell proliferation was not 
affected after 24 or 48 hours of Eu-doped HAp exposure. The cells adopted a normal 
morphology, each  having contact with the surrounding cells.  
  
Figure 10. Fluorescence images of HEK293 cells cultured in the presence of 100 µg/mL of 
Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) for 24 hours. Actin cytoskeleton of cells, stained with 
phalloidin-FITC (green), shows a apropriate morphology. The nuclei were counterstained with 
DAPI (blue). 
  
Figure 11. Fluorescence images of HEK293 cells cultured in the presence of 100 µg/mL of 
Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) for 48 hours. Actin cytoskeleton of cells, stained with 
phalloidin-FITC (green), shows a appropriate morphology. The nuclei were counterstained with 
DAPI (blue). 
 
It is notably that the cells are not disturbed by the presence of this type of hydroxyapatite, 
maintaining a healthy morphology and good adhesion. Moreover, it can also be remarked that the 
proliferative capacity of these cells was not affected compared to control cells. 
Heat shock proteins, Hsp60, Hsp70 and Hsp90 are molecular chaperones, and their 
expression is unregulated under many kinds of stresses, such as heat or chemical toxicity [53].  
As shown in Figure 12, cells exposed to different types and concentration of Eu doped HAp 
showed no important modifications of Hsp60, Hsp70 and Hsp90 expression compared to control 
cells. 
 
 
 Figure 12. Western blot analysis of Hsp60, Hsp70 and Hsp90. 
 
4. Discussion 
Hydroxyapatite presented in the recent years a significant interest for different fields such as 
pharmaceutics or biological and medical diagnostics [9, 54] due to the biocompatible and 
osteoconductive properties [55-56]. Based on the flexibility of the apatitic structure, HAp can 
incorporate a wide variety of substitutions for Ca2+, PO43, and/or OH- ions [57-61]. Since Eu3+ 
has a similar ionic radius to Ca2+, HAp is a good host for Eu3+. The substitution of Ca2+ by a Eu3+ 
ion has been achieved by various methods of synthesis such as solvothermal method [62], a 
combination of sol–gel and electrospinning processes [63]. R.S. André et al. [8] obtained Eu-
doped hydroxyapatite nanorods by HTMW method at 140◦C for 0, 1, 20 or 40 min. On the other 
hand, based on the flexibility of the apatitic structure I.R. Gibson et al. [64] has prepared by 
aqueous precipitation method the silicon-substituted hydroxyapatite.  
For this study, we synthesized the mesoporous and luminescent europium doped 
hydroxyapatite (Eu:HAp) powders with different concentration (xEu=0, xEu=0.01, xEu=0.02, 
xEu=0.2) by co-precipitation method at low temperature. Our previous XRD studies [12, 22] have 
shown that no other secondary phase such as calcium carbonate and/or europium oxide can be 
detected in XRD patterns. The results of XRD studies indicated that pure Eu:HAp nanoparticles 
were obtained by simple co-precipitation method. The HRTEM images and Selected Areas 
Electron Diffraction (SAED) of Eu:HAp nanoparticles confirms that the synthesized samples are 
well-crystallized single crystals even at small values of xEu. 
In FTIR analysis we observed that the contribution of the area that corresponds to the 
phosphate bands decreases when the Eu concentration in the samples increases. The bands at 475 
and 962 cm−1 progressively disappear with the increase of europium concentration. When the 
xEu=0.2 the bands at 475 and 962 cm−1 are almost absent. We can also observe in the Eu:HAp 
spectra a broadening of peak vibration with the decrease of the europium concentration. This 
behaviour was also observed by H. Owada et al. [65] in sintered Y-doped hydroxyapatite. 
The XPS results of the surface composition of the studied samples are according to the 
previous result obtained by C. Yang et al. [62]. This is the first comprehensive study in which a 
surface sensitive technique, XPS, has been employed to confirm the substitution of Ca2+ by Eu3+ 
into HAp. The analysis showed that when europium is present (Eu:HAp) the binding energies of 
Ca, P and O do not change when compared to the ones of pure HAp (xEu=0). On the other hand, 
the changes in the atomic percentages of the elements suggest a possible substitution of Ca by 
Eu. Regarding the Ca2p, P2p and O1s bands, there was no noticeable variation of their position 
when europium is present. The XPS results show that the P/O ratio remains relatively constant, 
the Ca/P ratio decreased while the Eu/Ca ratio increased. The (Ca+Eu)/P ratio obtained for the 
Eu:HAp (xEu=0.01, xEu=0.02, xEu=0.2) sample is practically the same as the Ca/P ratio of pure 
HAp (xEu=0). The fact that the ratio P/O is relatively constant in all the samples indicates that 
there was little or no loss of phosphate from the surface. 
The results of the nitrogen adsorption/desorption analysis indicates that the doping of Eu3+ 
has not altered the basic pore structure of the mesoporous HAp but improved the specific surface 
area of about 60% for low concentration to 100% to the highest concentration of Eu. 
Furthermore, in our study it can be noticed that in the cells treated with different types and 
concentrations of Eu doped HAp nanoparticles for 24 h and 48 h, F-actin distribution was around 
the nuclei and extended until the periphery of HEK 293 cells, which is in accordance with 
previous data [66-67]. The F-actin pattern was the same for control and exposed cells, which 
suggested a very low or a lack of toxicity of these types of nanoparticles. 
The induction of stress response proteins is highly conserved and protects different cells against 
several types of stressors [68]. Among the various stress response pathways, the gene expression 
and synthesis of different heat shock protein family members, such as Hsp 60, Hsp70 and Hsp 
90, are some of the key processes [69]. In non-stressed conditions, these proteins function as 
molecular chaperones, maintaining and facilitating the protein conformation and transport. In 
response to stress, heat shock proteins expression counteracts protein aggregation, promotes the 
degradation of highly denatured proteins and refolds the misfiled proteins or with damaged three 
dimensional structure [70].  
The Hsp70 chaperone systems play an essential role in hostile environments as well as 
under normal conditions. These are the most highly conserved and first to be induced in the 
presence of stressors [71]. The increased levels of Hsp70 have been considered as resulting due 
to the action of xenobiotics and/or their metabolites which have not been scavenged by 
detoxification processes and have affected the three dimensional structure of native proteins [72].  
Several studies revealed that metal based nanoparticles induced toxicity in a cell type dependent 
manner and the protein expression of Hsp70 was up-regulated [73-74]. Members of Hsp70 are 
found in the cytosol, nucleus, endoplasmic reticulum and mitochondrion [75]. In mitochondria, 
are also located mainly the members of Hsp 60 family proteins, coded by the nuclear genome, 
which play a significant role in polypeptide folding and in protein translocation [76]. 
In the same time, Hsp90 is the most abundant cytosolic heat shock protein family in eukaryotic 
cells and a decrease in its concentration is correlated with mortality in mammalian cells [71]. 
Recently, an increase of Hsp90 expression was noticed when melanoma targeted magnetite 
nanoparticles conjugated with a melanogenesis substrate were used [77]. 
Previous studies reported that in the cells exposed to hydroxiapatite based nanoparticles, 
a stress was developed [78-79]. This could be counteracted by an up-regulation of Hsps 
expression [74, 77]. Contrary to these observations, our study revealed no significant alteration 
of Hsp60, Hsp70 and Hsp90 expression.  
Based on the direct correlation between the level of stress and the protein expression of Hsps, it 
seems that the level of toxicity induced in HEK 293 cells by the exposure to these nanoparticles 
was low or absent. These results were valid for all concentrations of Eu doped HAp tested in this 
study and were not europium level dependent. 
5. Conclusion 
The results presented in this paper show the influence of the europium doping on 
hydroxyapatite bioceramics prepared by the co-precipitation method. XPS analysis indicated that 
Eu was able to quickly substitute Ca into the HAp by a co-precipitation method. High-resolution 
XPS analysis of the key elements of as-prepared samples, Ca, P, O and Eu indicated that 
distinctive photoelectron peaks could be attributed to the presence of Eu in the as-prepared 
samples with xEu=0.01, xEu=0.02, xEu=0.2. Europium did not change the chemistry or 
morphology of the pure HAp. After the europium doped hydroxyapatite the BET specific surface 
area of the as-prepared samples increased from pure HAp to Eu:HAp with xEu=0.20. The as-
prepared Eu:HAp samples exhibit mesoporous structure. The samples with a mesoporous 
structure are suitable for the drug delivery systems. 
The lack of cytotoxic effect on actin organisation and no stress response initiation in cells 
were highlighted. It seems that the cell compatibility with these Eu:HAp bioceramics correlates 
very well with its structure and nano dimension. 
Taken together, the normal aspect of F-actin filaments organization and heat shock proteins 
expression that remained almost unchanged support the idea that these Eu-doped HAp samples 
were not toxic and provided good conditions for cell proliferation. These sustain the applicability 
of europium-doped hydroxyapatite for medical purposes.     
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